16A-HYDROXY-PREDNISONLONE Cas:13951-70-7

We are 16A-HYDROXY-PREDNISONLONE CAS:13951-70-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Description:

Product Name: 16A-HYDROXY-PREDNISONLONE CAS NO: 13951-70-7

 

Synonyms:

11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione;

11,16a,17a,21-Tetrahydroxypregna-1,4-diene-3,20-dione;11β,16α,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione;

11β,16α,17α,21-Tetrahydroxypregna-1,4-diene-3,20-dione;

 

Chemical & Physical Properties:

Appearance: White crystalline solid

Assay :≥99.0%

Density: 1.38 g/cm3

Boiling Point: 591.5℃ at 760 mmHg

Melting Point: 235-238℃

Flash Point: 325.6℃

Refractive Index: 1.629

Vapor Pressure: 1.86E-16mmHg at 25℃

 

Safety Information:

HS Code: 2937210000

 

A metabolite of Budesonide, an antiinflammatory agent. 16α-Hydroxyprednisolone is a stereoselective metabolite of the 22(R) epimer of the glucocorticoid budesonide via cytochrome P450 3A (CYP3A) enzymes.

 

If you are interested in our products or have any questions, please feel free to contact us!

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.

Market News:The vaccine has been through the ringer over safety worries before. In April, U.S. authorities halted its use and later tagged it with a warning over reports of rare blood clots occurring alongside bleeding in some recipients. 1-(6-methoxy-9-tosyl-2,3,4,9-tetrahydro-1H-carbazol-4-yl)-N,N-dimethylmethanamine manufacturer.But one clear concern among the CDC’s expert group this time around was the rapidly spreading Delta variant, first found in India. That mutated strain now accounts for over 80% of new U.S. infections that are sequenced, CDC data shows. propan-2-yl N-[1-amino-2-(1,3-thiazol-4-yl)benzimidazol-5-yl]carbamate supplier.UK-headquartered Verona announced at the beginning of the year that it had completed enrolment in a pilot study evaluating the efficacy of ensifentrine delivered via pressurised metered-dose inhaler (pMDI) formulation in patients hospitalised with COVID-19. 1-([1,4′-bipiperidin]-1′-yl)-2-(4-amino-3-chloro-5-(trifluoromethyl)benzyl)-4-(4-(2-oxo-1,4-dihydroquinazolin-3(2H)-yl)piperidin-1-yl)butane-1,4-dione producer.